ibrutinib,zanubrutinib
abbvie,beigene,janssen
['lymsm', 'zanubrutinib', 'leusm', ' ibru']
#ash22 #leusm #lymsm brown: zan more effective in del17p/tp53m (2yr pfs 77.6% v 55.7%). orr 86.2% v 75.7%. overall tolerability similar but importantly significantly less afib w zan (5.2% v 13.3%). serious cards aes 1.9% (zan) v 7.7% 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)